Although CD8+ CTLs are best known as responders to eradicate malignant cells, studies have shown that CD4+ cytotoxic T cells existing naturally in the context of infectious diseases and cancers could directly kill infected or cancer cells (7–10). This evidence concerns the gene CD8A and cancer.